Large Molecule And Development Services

INC Research/inVentiv Health provides a full range of services needed to drive your large molecule development programs forward quickly and smoothly from discovery through post-marketing.

Significant experience in the development and validation of immunoassays for large molecules and biomarkers gives INC Research/inVentiv Health scientists special insight into the challenges of biotechnology product development. Work performed in our GLPcompliant immunochemistry facilities includes rigorously developed proprietary and non-proprietary pharmacokinetic assays to assess the bioavailability of novel and biosimilar products.

INC Research/inVentiv Health scientists understand the challenges of immunogenicity assay development. Rapidly providing specialized immunogenicity testing for the presence of antibodies to biologic and biosimilar product is a critical safety component of efficient large molecule drug development.

INC Research/inVentiv Health also offers as a range of cell-based and enzymatic assays to determine whether antibodies are blocking a drug's mechanism of action.